Laddar...
New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
Saxagliptin is a novel dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) for the treatment of type 2 diabetes, with a duration profile for once daily dosing. It is highly selective for DPP-4 in comparison to other enzymes of the dipeptidyl peptidase family. DPP-4 inhibitors elevate plasma concentra...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047961/ https://ncbi.nlm.nih.gov/pubmed/21437082 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|